Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
用户aKgJC6g3RnhA
2个月前
96
10
已完结
1. 系统已在2025-05-28 10:51:23对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acs.jmedchem.4c02720
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02720
其他信息:
出版社: American Chemical Society (ACS)
作者: Shixuan Jiao; Qiang Ren; Lianru Chen; Zongtao Zhou; Zongyu Cai; Wanqiu Huang; Bin Wang; Siliang Chen; Wenxin Wang; Zhijun Cao; Zhongcheng Yang; Qiqing Ye; Luyong Zhang; Zheng Li
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c02720
